Proceedings from the 2021 Hospital Medicine Summit – Monograph Evaluation (i801c)

Question Title

* 1. How many years have you been in practice?

>21

11-20

1-10

Question Title

* 2. Please select the option that best describes your practice setting.

Academic medical center

Community medical center

VA, DOD, or other government

Managed care

Research

Pharmaceutical industry

Question Title

* 3. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 5. What barriers do you see to making changes in your practice?

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement, or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Please rate your level of agreement with each of the following by checking the appropriate rating.

5=Strongly agree; 4=Agree; 3=Neutral; 2=Disagree; 1=Strongly disagree

Question Title

* 6. Restoring Balance From Hospital to Home: Updates on the Management of Acute and Chronic Hyperkalemia

After participating in this activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Discuss the importance of screening for, identifying, and assessing hyperkalemia	Discuss the importance of screening for, identifying, and assessing hyperkalemia Strongly agree	Discuss the importance of screening for, identifying, and assessing hyperkalemia Agree	Discuss the importance of screening for, identifying, and assessing hyperkalemia Neutral	Discuss the importance of screening for, identifying, and assessing hyperkalemia Disagree	Discuss the importance of screening for, identifying, and assessing hyperkalemia Strongly disagree
Describe current prescribing information for novel therapies for the effective management of acute and chronic hyperkalemia	Describe current prescribing information for novel therapies for the effective management of acute and chronic hyperkalemia Strongly agree	Describe current prescribing information for novel therapies for the effective management of acute and chronic hyperkalemia Agree	Describe current prescribing information for novel therapies for the effective management of acute and chronic hyperkalemia Neutral	Describe current prescribing information for novel therapies for the effective management of acute and chronic hyperkalemia Disagree	Describe current prescribing information for novel therapies for the effective management of acute and chronic hyperkalemia Strongly disagree
Discuss recent safety and efficacy data supporting the use of novel therapies in patients with hyperkalemia	Discuss recent safety and efficacy data supporting the use of novel therapies in patients with hyperkalemia Strongly agree	Discuss recent safety and efficacy data supporting the use of novel therapies in patients with hyperkalemia Agree	Discuss recent safety and efficacy data supporting the use of novel therapies in patients with hyperkalemia Neutral	Discuss recent safety and efficacy data supporting the use of novel therapies in patients with hyperkalemia Disagree	Discuss recent safety and efficacy data supporting the use of novel therapies in patients with hyperkalemia Strongly disagree
Review multidisciplinary strategies for achieving optimal outcomes from hospitalization through discharge and outpatient follow-up	Review multidisciplinary strategies for achieving optimal outcomes from hospitalization through discharge and outpatient follow-up Strongly agree	Review multidisciplinary strategies for achieving optimal outcomes from hospitalization through discharge and outpatient follow-up Agree	Review multidisciplinary strategies for achieving optimal outcomes from hospitalization through discharge and outpatient follow-up Neutral	Review multidisciplinary strategies for achieving optimal outcomes from hospitalization through discharge and outpatient follow-up Disagree	Review multidisciplinary strategies for achieving optimal outcomes from hospitalization through discharge and outpatient follow-up Strongly disagree

Question Title

* 7. The Role of Echocardiography in Early Detection and Evaluation of Treatment Response: Predicting Prognosis in Patients With Pulmonary Arterial Hypertension

After participating in this activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Describe the role of echocardiography in the early diagnosis of PAH and prediction of prognosis in patients with high-level risk factors	Describe the role of echocardiography in the early diagnosis of PAH and prediction of prognosis in patients with high-level risk factors Strongly agree	Describe the role of echocardiography in the early diagnosis of PAH and prediction of prognosis in patients with high-level risk factors Agree	Describe the role of echocardiography in the early diagnosis of PAH and prediction of prognosis in patients with high-level risk factors Neutral	Describe the role of echocardiography in the early diagnosis of PAH and prediction of prognosis in patients with high-level risk factors Disagree	Describe the role of echocardiography in the early diagnosis of PAH and prediction of prognosis in patients with high-level risk factors Strongly disagree
Summarize recent data regarding the impact of combination therapy on risk reduction and prognosis in patients with PAH	Summarize recent data regarding the impact of combination therapy on risk reduction and prognosis in patients with PAH Strongly agree	Summarize recent data regarding the impact of combination therapy on risk reduction and prognosis in patients with PAH Agree	Summarize recent data regarding the impact of combination therapy on risk reduction and prognosis in patients with PAH Neutral	Summarize recent data regarding the impact of combination therapy on risk reduction and prognosis in patients with PAH Disagree	Summarize recent data regarding the impact of combination therapy on risk reduction and prognosis in patients with PAH Strongly disagree
Discuss the value of patient-focused management and interdisciplinary approaches to support the care of patients with PAH	Discuss the value of patient-focused management and interdisciplinary approaches to support the care of patients with PAH Strongly agree	Discuss the value of patient-focused management and interdisciplinary approaches to support the care of patients with PAH Agree	Discuss the value of patient-focused management and interdisciplinary approaches to support the care of patients with PAH Neutral	Discuss the value of patient-focused management and interdisciplinary approaches to support the care of patients with PAH Disagree	Discuss the value of patient-focused management and interdisciplinary approaches to support the care of patients with PAH Strongly disagree

Question Title

* 8. Getting It Right the First Time: Antiplatelet Therapy for Secondary Stroke Prevention

After participating in this activity, I am now better able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Describe the epidemiology and disease burden of primary and recurrent stroke	Describe the epidemiology and disease burden of primary and recurrent stroke Strongly agree	Describe the epidemiology and disease burden of primary and recurrent stroke Agree	Describe the epidemiology and disease burden of primary and recurrent stroke Neutral	Describe the epidemiology and disease burden of primary and recurrent stroke Disagree	Describe the epidemiology and disease burden of primary and recurrent stroke Strongly disagree
Summarize modifiable risk factors and current guideline recommendations into the effective prevention of recurrent secondary stroke	Summarize modifiable risk factors and current guideline recommendations into the effective prevention of recurrent secondary stroke Strongly agree	Summarize modifiable risk factors and current guideline recommendations into the effective prevention of recurrent secondary stroke Agree	Summarize modifiable risk factors and current guideline recommendations into the effective prevention of recurrent secondary stroke Neutral	Summarize modifiable risk factors and current guideline recommendations into the effective prevention of recurrent secondary stroke Disagree	Summarize modifiable risk factors and current guideline recommendations into the effective prevention of recurrent secondary stroke Strongly disagree
Define the evolving standard of care in secondary stroke prevention evidenced by recent clinical trial outcomes involving antiplatelet therapies and anticoagulants	Define the evolving standard of care in secondary stroke prevention evidenced by recent clinical trial outcomes involving antiplatelet therapies and anticoagulants Strongly agree	Define the evolving standard of care in secondary stroke prevention evidenced by recent clinical trial outcomes involving antiplatelet therapies and anticoagulants Agree	Define the evolving standard of care in secondary stroke prevention evidenced by recent clinical trial outcomes involving antiplatelet therapies and anticoagulants Neutral	Define the evolving standard of care in secondary stroke prevention evidenced by recent clinical trial outcomes involving antiplatelet therapies and anticoagulants Disagree	Define the evolving standard of care in secondary stroke prevention evidenced by recent clinical trial outcomes involving antiplatelet therapies and anticoagulants Strongly disagree
List practical strategies to enhance a multi-disciplinary approach to improve secondary stroke prevention	List practical strategies to enhance a multi-disciplinary approach to improve secondary stroke prevention Strongly agree	List practical strategies to enhance a multi-disciplinary approach to improve secondary stroke prevention Agree	List practical strategies to enhance a multi-disciplinary approach to improve secondary stroke prevention Neutral	List practical strategies to enhance a multi-disciplinary approach to improve secondary stroke prevention Disagree	List practical strategies to enhance a multi-disciplinary approach to improve secondary stroke prevention Strongly disagree

Question Title

* 9. Alpesh Amin, MD, MBA, MACP, SFHM, FACC, FRCP, FHSA, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided Bias	Avoided Bias Strongly agree	Avoided Bias Agree	Avoided Bias Neutral	Avoided Bias Disagree	Avoided Bias Strongly disagree
The teaching and learning methods were effective	The teaching and learning methods were effective Strongly agree	The teaching and learning methods were effective Agree	The teaching and learning methods were effective Neutral	The teaching and learning methods were effective Disagree	The teaching and learning methods were effective Strongly disagree
The learning assessment used for this activity was appropriate	The learning assessment used for this activity was appropriate Strongly agree	The learning assessment used for this activity was appropriate Agree	The learning assessment used for this activity was appropriate Neutral	The learning assessment used for this activity was appropriate Disagree	The learning assessment used for this activity was appropriate Strongly disagree

Question Title

* 10. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 13. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 14. Participant Information

First Name

Last Name

Degree

E-mail

Question Title

* 1. How many years have you been in practice?

Question Title

* 2. Please select the option that best describes your practice setting.

Question Title

* 3. Which of the following best describes the impact of this activity on your performance?

Question Title

* 4. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 5. What barriers do you see to making changes in your practice?

Question Title

* 6. Restoring Balance From Hospital to Home: Updates on the Management of Acute and Chronic HyperkalemiaAfter participating in this activity, I am now better able to:

Question Title

* 7. The Role of Echocardiography in Early Detection and Evaluation of Treatment Response: Predicting Prognosis in Patients With Pulmonary Arterial HypertensionAfter participating in this activity, I am now better able to:

Question Title

* 8. Getting It Right the First Time: Antiplatelet Therapy for Secondary Stroke PreventionAfter participating in this activity, I am now better able to:

Question Title

* 9. Alpesh Amin, MD, MBA, MACP, SFHM, FACC, FRCP, FHSA, effectively:

Question Title

* 10. The content presented:

Question Title

* 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 13. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 14. Participant Information

* 6. Restoring Balance From Hospital to Home: Updates on the Management of Acute and Chronic Hyperkalemia

After participating in this activity, I am now better able to:

* 7. The Role of Echocardiography in Early Detection and Evaluation of Treatment Response: Predicting Prognosis in Patients With Pulmonary Arterial Hypertension

After participating in this activity, I am now better able to:

* 8. Getting It Right the First Time: Antiplatelet Therapy for Secondary Stroke Prevention

After participating in this activity, I am now better able to: